Skip to main content
SpringerLink
Log in

Progressionshemmung bei chronischen Nierenerkrankungen

  • Published:
Der Urologe B Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Attman PO (1998) Progression of renal failure and lipids — is there evidence for a link in humans? Nephrol Dial Transplant 13:545–547

    Article  CAS  PubMed  Google Scholar 

  2. Black HR, Zeevi GR, Silten RM, Walker-Smith GJ (1983) Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 34:173–179

    Article  CAS  PubMed  Google Scholar 

  3. Brenner BM (1985) Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324–F337

    CAS  PubMed  Google Scholar 

  4. Burton C, Harris KP (1996) The Role of Proteinuria in the Progression of Chronic Renal Failure. Am J Kidney Dis 27:765–775

    Article  CAS  PubMed  Google Scholar 

  5. Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D (1998) The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 13:1682–1685

    Article  CAS  PubMed  Google Scholar 

  6. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE (1991) Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265:614–617

    Article  CAS  PubMed  Google Scholar 

  7. Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD (1993) Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int 43:808–814

    Article  CAS  PubMed  Google Scholar 

  8. Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE (1995) Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963–1974

    CAS  PubMed  Google Scholar 

  9. GISEN group (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857–1863

    Article  Google Scholar 

  10. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Weder H, Westerling S (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351: 1755–1562

    Article  CAS  PubMed  Google Scholar 

  11. Kasiske BL, Lakatua JDA, Ma JZ, Louis TA (1998) A Meta-Analysis of the Effects of Dietary Protein Restriction on the Rate of Decline in Renal Function. Am J Kidney Dis 31:954–961

    Article  CAS  PubMed  Google Scholar 

  12. Keane WF (1993) Lipids and the kidney. Kidney Int 46:910–920

    Article  Google Scholar 

  13. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G for the modification of diet in renal disease study group (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877–884

    Article  CAS  PubMed  Google Scholar 

  14. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462

    Article  CAS  PubMed  Google Scholar 

  15. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334: 939–945

    Article  CAS  PubMed  Google Scholar 

  16. Massy ZA, Nguyen Khoa T, Lacour B, Descamps-Latscha B, Khoa Man N, Jungers P (1999) Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 14: 2392–2406

    Article  CAS  PubMed  Google Scholar 

  17. Obrador GT, Pereira BJ (1998) Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 31:398–417

    Article  CAS  PubMed  Google Scholar 

  18. Orth SR, Stöckmann A, Conradt C, Ritz E (1998) Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54:926–931

    Article  CAS  PubMed  Google Scholar 

  19. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754–762

    Article  CAS  PubMed  Google Scholar 

  20. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G for the GISEN study group (1998) Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 53: 1209–1216

    Article  CAS  PubMed  Google Scholar 

  21. Stiefel M, Verberckmoes R, Ritz E (1989) Is asymptomatic hyperuricemia in kidney-failure patients in need of therapy? Dtsch Med Wochenschr 114:964–968

    Article  CAS  PubMed  Google Scholar 

  22. Strutz F, Müller GA (1999) Interstitial Pathomechanisms Underlying Progressive Tubulointerstitial Damage. Kidney Blood Press Res 22: 71–80

    Article  CAS  PubMed  Google Scholar 

  23. Throssell D, Brown J, Harris KPG, Walls J (1995) Metabolic acidosis does not contribute to chronic renal injury in the rat. Clin Sci 89:643–650

    CAS  PubMed  Google Scholar 

  24. United States Renal Data System.USRDS 1995 Annual Data Report. U. S. Department of Health and Human Services.The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, August 1995

  25. Weidmann P, Schneider M, Böhler L (1995) Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis. Nephrol Dial Transplant (Suppl 9): 39-45

  26. Wrenger E, Bahlmann J, Floege J (1996) Harnsäure und tubulo-interstitielle Nierenerkrankungen. Internist 37:1137–1142

    CAS  PubMed  Google Scholar 

  27. Zucchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelli M, Stallone C, Sanna G, Gaggi R (1992) Long-term comparison between captopril and nifedipin in the progression of renal insufficiency. Kidney Int 42: 452–458

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Innere Medizin IV, Schwerpunkt Nephrologie, Universitätskliniken des Saarlandes, Kirrbergerstraße, D-66421, Homburg/Saar

    G. Heine, M. Girndt, M. K. Kuhlmann &  H. Köhler

Authors
  1. G. Heine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Girndt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. K. Kuhlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Köhler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heine, G., Girndt, M., Kuhlmann, M.K. et al. Progressionshemmung bei chronischen Nierenerkrankungen. Der Urologe B 40, 83–92 (2000). https://doi.org/10.1007/s001310050019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050019

Search

Navigation